Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Annual General Meeting

GlaxoSmithKline Pharmaceuticals Annual General Meeting

GlaxoSmithKline Pharmaceuticals Ltd announced that shareholders approved the appointment of Mr. Ronojit Biswas as Director and Whole-time Director & CFO via postal ballot. The ordinary resolutions were passed with over 99.6% majority. This confirms leadership stability for the company's financial and administrative operations.

Source

BSE filing, NSE: GLAXO. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

GlaxoSmithKline Pharmaceuticals Ltd: key numbers

Share price
₹2,498.00
Market cap
₹42,318 Cr
Revenue (annual)
₹3,822 Cr
Net profit (annual)
₹1,036 Cr
P/E (TTM)
39.6×Sector 46.1×
Promoter holding
75.00%+0.00% QoQ
FII holding
4.75%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from GlaxoSmithKline Pharmaceuticals Ltd

All →

Other annual general meeting announcements

All →